CURRENT REPORT

Company

CNS Pharmaceuticals, Inc.

Filed

July 9, 2024

Period of Report

July 5, 2024

Accession Number

0001683168-24-004708

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →